Spelman Chemistry Majors are at the Forefront of Cancer Research
In April of this year, I took six of my research students to the Annual Meeting of the American Association for Cancer Research in Chicago. While there, I received a national award, the 2012 Minority Serving Institutions Faculty Research award for my efforts in cancer therapeutics and student training.
At the international meeting, my students participated in the 7th Annual Undergraduate Student Caucus & Poster Competition. Spelman College was one a few undergraduate colleges competing against a host of comprehensive cancer centers, research institutes and universities. Kwadernica Rhea and Nakisha Rutledge (co-author) placed fourth (honorable mention) in the overall poster competition on their work titled, Glucocorticoid Receptor Signaling Pathway targeted for treatment of Hormone Refractory Prostate Cancer.
The students attending were (L to R on attached pic): Emma Carine Iradukunda(Rwandan Presidential Scholar); Rosine Dushime(HHMI and Rwandan Presidential Scholar) ; Lydia Ruffin(MBRS-RISE scholar and winner of the chemistry poster section for Spelman Research day); Evan DuBose( MBRS-RISE scholar); Nakisha Rutledge(MBRS-RISE scholar); and Kwadernica Rhea(HHMI scholar). Each of these talented researchers also just completed prestigious summer internships at LSU, Georgia Tech, Boston University, UNC-Chapel Hill, Northwestern, and University of Wisconsin-Madison, respectively.
NOTE: Take a look at the link and look at the list of winners. You will see that Spelman was the only HBCU and only undergraduate institution to be recognized under the list of winners.
Kimberly M. Jackson, Ph.D.
Learn more about Dr. Jackson and her research
Kimberly M. Jackson, PhD
Department of Chemistry
350 Spelman Lane, SW
Atlanta, GA 30314
“Spelman allows me to empower women of color to do dynamic science,” said Dr. Jackson, who has mentored more than 30 students since arriving at Spelman College in 2002, providing them with research experiences in cancer therapeutics and drug discovery. “My recent tenure and promotion to associate professor of chemistry has given me the stability I need to continue training junior investigators and challenging them more academically. I also anticipate my research aspirations continuing to thrive and elevate to new heights.”
Dr. Jackson has been awarded close to $1 million in federal and private grant funds to investigate new therapies for advanced prostate cancer. In 2009, she was the recipient of a prestigious Marine Biological Laboratory Research Award. More recently, she has been awarded a visiting faculty appointment at Harvard Medical School in the Systems Biology department to continue her prostate cancer research.